Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 5, 1997

View Archived Issues

Insulin mediator isolated from beef liver

Pause in SNX-111 head trauma trial enrollment announced

Vertex acquires ICE patent portfolio from Sanofi

New antiatherosclerotic beta-lactams from SmithKline Beecham

Sanofi compounds with potent and selective affinity for CB2 receptors

Nonpeptide NK3 antagonists from SmithKline Beecham

Leukotriene synthesis inhibitors in development at Bayer

Procept awarded grant for tuberculosis vaccine research

KSA-based cancer vaccine in development

Zeneca invests in zolmitriptan manufacturing in Puerto Rico

Finasteride halts male hair loss

Cortecs confirms Helisal distribution agreement with Zenyaku Kogyo

Use of PET in dementia diagnosis

U.S. patent issues for bone substitute technology

Bioniche to manufacture Orphan Medical's Intrachol

EGS oligozymes make drug-resistant bacteria sensitive

Sibutramine: New hope for obese patients

New H. pylori immunoassay now available in the U.K.

Anti-IL-4 MAb effective in murine model of asthma

Efficacy of sumatriptan evaluated in children

Rezulin receives FDA marketing clearance for type 2 diabetes

Diatide allowed two U.S. patents for thrombus imaging

Recombinant Biocatalysis changes name to Diversa; broadens technology platform

Tonalin CLA reduces body fat

CombiChem and Sumitomo establish drug discovery collaboration

Lilly creates new business unit dedicated to women's health

PEG-Intron A progresses to phase III for treatment of hepatitis C

New direction in NOS research: Potential application in gene therapy of impotence

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...